LivaNova PLC (NASDAQ:LIVN) shares were down 6% during mid-day trading on Tuesday . The company traded as low as $82.35 and last traded at $82.74. Approximately 548,400 shares changed hands during trading, an increase of 40% from the average daily volume of 391,747 shares. The stock had previously closed at $88.00.
Several research analysts recently weighed in on LIVN shares. ValuEngine upgraded shares of LivaNova from a “hold” rating to a “buy” rating in a report on Thursday, November 2nd. WBB Securities lowered shares of LivaNova from a “hold” rating to a “sell” rating and set a $50.00 price target on the stock. in a research report on Tuesday, August 15th. Canaccord Genuity reissued a “hold” rating and issued a $76.00 price target on shares of LivaNova in a research report on Tuesday. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $75.00 target price on shares of LivaNova in a report on Tuesday, September 12th. Finally, Needham & Company LLC upped their target price on shares of LivaNova from $93.00 to $97.00 and gave the stock a “buy” rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $79.71.
The company has a quick ratio of 1.42, a current ratio of 2.03 and a debt-to-equity ratio of 0.04. The firm has a market cap of $4,032.42, a P/E ratio of 24.10, a P/E/G ratio of 2.51 and a beta of 0.61.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $74.58, for a total transaction of $74,580.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Alfred J. Novak sold 2,000 shares of the stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $85.77, for a total value of $171,540.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,830 shares of company stock worth $557,100. Corporate insiders own 0.28% of the company’s stock.
Several large investors have recently made changes to their positions in LIVN. PNC Financial Services Group Inc. raised its stake in LivaNova by 9.8% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after purchasing an additional 153 shares during the last quarter. Riverhead Capital Management LLC increased its position in shares of LivaNova by 76.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock worth $108,000 after purchasing an additional 763 shares during the last quarter. Shelton Capital Management acquired a new stake in shares of LivaNova during the 3rd quarter worth about $209,000. Teacher Retirement System of Texas purchased a new position in LivaNova during the 2nd quarter valued at about $204,000. Finally, Martingale Asset Management L P purchased a new position in LivaNova during the 2nd quarter valued at about $221,000. Hedge funds and other institutional investors own 86.07% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.com-unik.info/2017/12/07/livanova-livn-shares-down-6.html.
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
What are top analysts saying about LivaNova PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LivaNova PLC and related companies.